The DRC orders one million Mpox tests from Contipharma of Liège

The importance of rapid screening in the fight against the epidemic! Contipharma on the front line.
‘Rapid screening is essential to prevent and control the epidemic,
“Rapid screening is essential to prevent and control the epidemic, according to Bernard DELHEZ, CEO, who is this week in the Democratic Republic of Congo, the epicentre of the MPOX epidemic, where more than 1,000 new cases were reported last week, according to ECOFIN Africa” … The DRC has placed an order with Contipharma for one million of its rapid antigenic tests to detect the virus and has announced a €49 million plan to counter the alarming spread of the virus.

This is a first step before the arrival of the new generation of Mpox screening tests, the LAMPOX ™ currently under evaluation, developed and perfected by Contipharma with the support of INRB in Kinshasa.